The Pharmacy Times® Asthma Resource Center is a comprehensive resource for clinical news and expert insights on issues related to the treatment of the chronic lung disease, in which the airways narrow and swell.
January 20th 2025
The authors found that humidity, cold and heat waves, and air pollution led to a higher likelihood of asthma- and chronic obstructive pulmonary disease (COPD)-related hospitalizations.
Symbicort Now Approved for Young Children
January 28th 2017Officials with AstraZeneca recently announced that the FDA has expanded the indication of its 80/4.5 mcg budesonide and formoterol fumarate dihydrate inhalation aerosol (Symbicort), approving the drug for the treatment of asthma in patients aged 6 to 12 years.
Read More